References
- Vazquez V, Calderon E, Rodriguez R S. Chloramphenicol-resistant strains of Salmonella typhosa. N Engl J Med 1972; 286: 1220
- Overturf G, Morton K I, Mathies A W. Antibiotic resistance in typhoid fever. Chloramphenicol resistance among clinical isolates of Salmonella typhosa in Los Angeles, 1972 – Epidemiologic and bacteriologic characteristics. N Engl J Med 1973; 289: 463–465
- Goldstein F W, Chumpitaz J C, Guevara J M, Papadopoulou B, Acar J F, Vieu J F. Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis 1986; 153: 261–266
- McKendrick M W, Geddes A M, Wise R, Bax R. Cefotaxime in septicaemia including typhoid fever. J Antimicrob Chemother 1980; 6(Suppl A)277–281
- Pape J W, Gerdes H, Oriol L, Johnson W D. Typhoid fever: Successful therapy with cefoperazone. J Infect Dis 1986; 153: 272–276
- Ti T, Monteiro E H, Lam S, Lee H. Ceftriaxone therapy in bacteremic typhoid fever. Antimicrob Agents Chemother 1985; 28: 540–543
- Soe G B, Overturf G D. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins. Rev Infect Dis 1987; 9: 719–736
- Islam A, Butler T, Nath S K, Alam N H, Stockel K, Houser H B, Smith A L. Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. J Infect Dis 1988; 158: 742–747
- Moosa A, Rubidge C J. Once daily ceftriaxone vs. chloramphenicol for treatment of typhoid fever in children. Pediatr Infect Dis J 1989; 8: 696–699
- Asperilla M O, Smego R A, Jr, Scott L K. Quinolone antibiotics in the treatment of salmonella infection. Rev Infect Dis 1990; 12: 873–889
- Christ W, Lehnert T, Ulbrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988; 10(Suppl 1)S141–146
- Bhutta Z A, Naqvi S H, Razzaq R A, Farooqui B J. Multiple drug-resistant typhoid in children. Presentation and clinical features. Rev Infect Dis 1991; 13: 832–836
- Waterworth P M. Quantitative methods for bacterial sensitivity testing. Laboratory methods in antimicrobial chemotherapy, D S Reeves, I Phillips, J D Williams, R Wise. Churchill Livingston Press, Edinburgh 1984
- Goosens H, DeMol P, Coignau H, Levy J, Grados O, Guido G, Innocent H, Butzler J P. Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, HR 810 (a new cephalosporin), RU 28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother 1985; 27: 388–392
- Campoli-Richards D M, Monk J P, Price A, Benfield P, Todd P A, Ward A. Ciprofloxacin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1988; 35: 373–447
- Patel I H, Kaplan S A. Pharmacokinetic profile of ceftriaxone in man. Am J Med 1984; 77: 17–25
- Punjabi N H, Hoffman S L, Edman D C, Sukri N, Laughlin L W, Pulungsih S P, Rivai A R, Sutoto, Moechtar A, Woodward T E. Treatment of severe typhoid fever in children with high dose dexamethasone. Pediatr Infect Dis J 1988; 7: 598–600
- Edelman R, Levine M M. Summary of an international workshop on typhoid fever. Rev Infect Dis 1986; 8: 329–349